Literature DB >> 32930109

An updated meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer.

Tao Liu1, Wen-Zhou Liu1, Yu Sun1, Xiao-Han Bi1, Hua-Fu Zhou1.   

Abstract

AIM OF STUDY: There were many reports published on the relationship between glutathione S-transferase T1 (GSTT1) null/presence gene polymorphism and the risk of lung cancer in these years. In previous, we conducted a meta-analysis to evaluate the relationship between GSTT1 null/presence gene polymorphism and the risk of lung cancer. This study was conducted to update it.
MATERIALS AND METHODS: The association studies were identified from PubMed and Cochrane Library on March 1, 2016.
RESULTS: Sixty-three reports were recruited into this meta-analysis for the association of null genotype of GSTT1 with lung cancer susceptibility, consisting of 21,220 patients with lung cancer and 21,496 controls. There was a marked association between GSTT1 null genotype and lung cancer risk in overall populations and in Asians (overall populations: Odds ratio [OR] = 1.17, 95% confidence interval [95% CI]: 1.07-1.28, P = 0.006; Asians: OR = 1.41, 95% CI: 1.23-1.62, P < 0.00001). However, GSTT1 null genotype was not associated with the risk of lung cancer in Caucasians, Brazilian population, and Africans.
CONCLUSION: GSTT1 null genotype is associated with the lung cancer risk in overall populations and in Asians.

Entities:  

Keywords:  Gene polymorphism; glutathione S-transferase T1; lung cancer; updated meta-analysis

Mesh:

Substances:

Year:  2020        PMID: 32930109     DOI: 10.4103/0973-1482.189237

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  1 in total

1.  Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.

Authors:  Sahar E M El-Deek; Soad M Abdel-Ghany; Randa S Hana; Aliaa A R Mohamed; Naglaa T El-Melegy; Ayat A Sayed
Journal:  Mol Biol Rep       Date:  2021-05-30       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.